According to DelveInsight’s analysis, Dilated Cardiomyopathy prevalence was recorded to be 2,486,633 in 2017, which is expected to be 2,523,808 by 2020 and grow by 2030.
The United States accounted for the highest Dilated Cardiomyopathy prevalence in the seven major markets.
The Dilated Cardiomyopathy Market Size in the 7MM is expected to increase from USD 244 Million in 2017 by 2030.
The key companies in the Dilated Cardiomyopathy Market include Pfizer, MyoKardia, Vericel, Capricor Therapeutics, Cumberland Pharmaceuticals, Berlin Cures and others.
For more details visit: https://www.delveinsight.com/blog/dilated-cardiomyopathy-market-dcm-market/